Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects.
BACKGROUND
Iron supplements may inhibit intestinal zinc and copper uptake because these elements may compete for binding to a transporter molecule (divalent metal transporter 1) that is located on the apical side of the small intestinal epithelium.


OBJECTIVE
We quantified the interaction between different amounts of administered iron and the absorption of zinc and copper in humans.


METHODS
Eleven subjects with an ileostomy [mean (+/- SD) age: 55 +/- 9 y] ingested a stable-isotope-labeled zinc and copper solution containing 12 mg Zn ((66)Zn and (67)Zn) and 3 mg Cu ((65)Cu) in the presence of 0, 100, or 400 mg Fe as ferrous gluconate on 3 respective test days. Subsequently, 1 mg (70)Zn was injected intravenously. Subjects collected ileostomy effluent and urine for 24 h and 7 d, respectively. Zinc status and true zinc absorption were calculated from the urinary excretion of the zinc isotopes. Apparent copper absorption was calculated from ileostomy effluent excretion of the orally administered copper isotopes.


RESULTS
Zinc status did not differ significantly between the 3 iron doses. Mean (+/- SEM) zinc absorption was significantly higher in the absence of iron than with the concomitant ingestion of 100 or 400 mg Fe (44 +/- 22% compared with 26 +/- 14% and 23 +/- 6%, respectively; P < 0.05), whereas zinc absorption did not differ significantly between the 100- and 400-mg Fe doses. Apparent copper absorption was 48 +/- 14%, 54 +/- 26%, and 53 +/- 7% in the presence of 0, 100, and 400 mg Fe, respectively, and did not differ significantly between the 3 iron doses.


CONCLUSIONS
Oral iron therapy may impair zinc absorption and thus zinc status in a dose-independent fashion but does not affect copper absorption.
Troost
Freddy J
FJ
Department of Human Biology, NUTRIM, Maastricht University, Maastricht, Netherlands. f.troost@hb.unimaas.nl
Brummer
Robert-Jan M
RJ
Dainty
Jack R
JR
Hoogewerff
Jurian A
JA
Bull
Vicky J
VJ
Saris
Wim H M
WH
D002097:C-Reactive Protein / Q000032:analysis; D003300:Copper / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019587:Dietary Supplements; D004347:Drug Interactions; D005260:Female; D005293:Ferritins / Q000097:blood; D005296:Ferrous Compounds / Q000008:administration & dosage; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007081:Ileostomy; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D019266:Iron, Dietary / Q000008:administration & dosage / Q000009:adverse effects*; D007554:Isotopes; D008297:Male; D008875:Middle Aged; D009752:Nutritional Status; D015032:Zinc / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000652:urine; D015033:Zinc Isotopes
D005296:Ferrous Compounds; D006454:Hemoglobins; D019266:Iron, Dietary; D007554:Isotopes; D015033:Zinc Isotopes; D003300:Copper; D002097:C-Reactive Protein; D005293:Ferritins; D015032:Zinc; C011819:ferrous gluconate